Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.208 SEK | -2.58% | -11.49% | -97.92% |
04-22 | Transcript : Xbrane Biopharma AB - Special Call | |
03-18 | Xbrane Biopharma AB(OM:XBRANE) dropped from S&P Global BMI Index | CI |
Business Summary
Number of employees: 93
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 58 | 100.0 % | 239 | 100.0 % | +314.33% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
88.0
%
| 7 | 11.6 % | 210 | 88.0 % | +3,034.33% |
North America
12.0
%
| 51 | 88.4 % | 29 | 12.0 % | -43.61% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Martin Åmark
CEO | Chief Executive Officer | 44 | 31/12/14 |
Anette Lindqvist
DFI | Director of Finance/CFO | 63 | 10/01/21 |
Dina Jurman
CTO | Chief Tech/Sci/R&D Officer | 42 | 08/10/17 |
David Vikström
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/12/13 |
Siavash Bashiri
COO | Chief Operating Officer | 41 | 31/12/14 |
Nina Ivers
HRO | Human Resources Officer | 54 | 15/12/20 |
Xiaoli Hu
PRN | Corporate Officer/Principal | 42 | 30/04/20 |
Maria Edebrink
LAW | General Counsel | 55 | 31/12/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 31/12/14 | |
Director/Board Member | 70 | 31/12/14 | |
Director/Board Member | 53 | 31/12/19 | |
Eva Nilsagård
BRD | Director/Board Member | 60 | 15/05/19 |
Director/Board Member | - | 15/05/19 | |
Kirsti Gjellan
BRD | Director/Board Member | 61 | 04/05/22 |
Chairman | 63 | 02/04/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,520,328,564 | 1,357,063,187 ( 89.26 %) | 0 | 89.26 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.92% | 29.11M | |
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- XBRANE Stock
- Company Xbrane Biopharma AB